Related Experiment Video

Updated: May 23, 2026

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

Aberrant B-Raf signaling in human cancer -- 10 years from bench to bedside

Michael Röring1, Tilman Brummer

  • 1Spemann Graduate School of Biology and Medicine, Centre for Biological Systems Analysis, Faculty for Biology, Albert-Ludwigs-University of Freiburg, Germany.

Critical Reviews in Oncogenesis
|April 5, 2012
PubMed

Insights

The Ras/Raf/MEK/ERK pathway regulates cell growth; BRAF mutations drive cancer but lead to drug resistance. This review covers BRAF regulation, mutations in malignancies, and resistance mechanisms to targeted therapies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Signal Transduction

Background:

  • The Ras/Raf/MEK/ERK pathway is crucial for cell function and implicated in cancers and developmental disorders.
  • B-Raf is a key regulatory node in this pathway and is the most frequently mutated protein kinase gene in human tumors.
  • BRAF mutations are common in difficult-to-treat cancers like melanoma, ovarian, and colorectal carcinoma.

Purpose of the Study:

  • To review the physiological regulation of the B-Raf kinase.
  • To discuss how mutations lead to dysregulation of B-Raf in cancer.
  • To update on malignancies with high BRAF mutation frequencies and resistance mechanisms to B-Raf inhibitors.

Main Methods:

  • Literature review of B-Raf regulation, mutations, and inhibitor therapies.
  • Analysis of current knowledge on physiological control and oncogenic mutations of BRAF.
  • Synthesis of data on clinical responses and resistance mechanisms to B-Raf inhibitors.

Main Results:

  • B-Raf mutations are frequent drivers in various human cancers, including melanoma.
  • Targeted B-Raf inhibitors show high initial response rates in metastatic melanoma.
  • Therapeutic efficacy is limited by the rapid emergence of resistance mechanisms.

Conclusions:

  • Understanding B-Raf regulation and mutation is critical for cancer therapy.
  • B-Raf inhibitors offer promise but require strategies to overcome resistance.
  • Further research is needed to address side effects and resistance in BRAF-mutated cancers.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis09:45

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis

Published on: March 31, 2015

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...